Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Weiser

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
Diseases of the Colon and Rectum|June 17, 2006
Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment resultsGenevieve B Melton, Philip B Paty, Patrick J Boland, et al.
JAMA Oncology|December 23, 2017
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer OutcomeTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.
Annals of Surgical Oncology|May 3, 2024
Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural NetworkHannah Williams, Hannah M Thompson, Christina Lee, et al.
Annals of Surgical Oncology|October 24, 2017
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic OutcomeMichael J Cavnar, Lin Wang, Vinod P Balachandran, et al.
The American Journal of Surgical Pathology|August 25, 2009
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panelJinru Shia, Laura H Tang, Efsevia Vakiani, et al.
Diseases of the Colon and Rectum|November 22, 2021
MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount PathologyJonathan B Yuval, Hannah M Thompson, Canan Firat, et al.
Abdominal Radiology (New York)|June 29, 2019
Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluationJennifer S Golia Pernicka, Johan Gagniere, Jayasree Chakraborty, et al.
The American Journal of Surgical Pathology|December 18, 2010
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapyJinru Shia, Martine McManus, Jose G Guillem, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockadeTao Wang, Lik Hang Lee, Monika Vyas, et al.
Diseases of the Colon and Rectum|September 14, 2022
Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality TherapyJames P Taylor, Iris H Wei, J Joshua Smith, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
Diseases of the Colon and Rectum|June 17, 2006
Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment resultsGenevieve B Melton, Philip B Paty, Patrick J Boland, et al.
JAMA Oncology|December 23, 2017
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer OutcomeTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.
Annals of Surgical Oncology|May 3, 2024
Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural NetworkHannah Williams, Hannah M Thompson, Christina Lee, et al.
Annals of Surgical Oncology|October 24, 2017
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic OutcomeMichael J Cavnar, Lin Wang, Vinod P Balachandran, et al.
The American Journal of Surgical Pathology|August 25, 2009
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panelJinru Shia, Laura H Tang, Efsevia Vakiani, et al.
Diseases of the Colon and Rectum|November 22, 2021
MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount PathologyJonathan B Yuval, Hannah M Thompson, Canan Firat, et al.
Abdominal Radiology (New York)|June 29, 2019
Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluationJennifer S Golia Pernicka, Johan Gagniere, Jayasree Chakraborty, et al.
The American Journal of Surgical Pathology|December 18, 2010
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapyJinru Shia, Martine McManus, Jose G Guillem, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockadeTao Wang, Lik Hang Lee, Monika Vyas, et al.
Diseases of the Colon and Rectum|September 14, 2022
Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality TherapyJames P Taylor, Iris H Wei, J Joshua Smith, et al.
Pageof 30